Clin2
NCT07174830Worth exploringRecruiting

Study of Allisartan Isoproxil in healthy adults

Healthy Participants

Treatments studied

This trial tests how the body processes the blood pressure medication Allisartan Isoproxil. It is for healthy adults who want to help researchers understand the drug's effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
54 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • Your weight is at least 50 kg (men) or 45 kg (women), with a BMI between 19 and 25.
  • Your sitting blood pressure is in a healthy range (systolic 100-139, diastolic 70-89) and you don't have drops in blood pressure when standing.
  • You are generally healthy, with no significant medical conditions or abnormal lab results.
  • You agree to avoid certain medications, supplements, caffeine, alcohol, smoking, and grapefruit during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07463196Recruiting· Phase 1
Study of ACI-19764 for healthy people and those with heart risks

This trial tests an experimental drug called ACI-19764 to see how safe it is, how the body handles it, and how it affects the immune system. It's for healthy adults and for adults with heart-related risk factors like obesity or type 2 diabetes.

Groningen
NCT03264352Recruiting· Phase 4
Treatment for slightly high blood pressure in type 2 diabetes

This trial tests an intervention to help adults with type 2 diabetes who have “high-normal” blood pressure (not severely high). If you qualify, you may learn whether this approach improves blood pressure and related health outcomes over time.

Guangzhou, Guangdong
NCT07555054Not yet recruiting· Phase 2
Study of a new medicine for chronic kidney disease

This study tests a new medicine called HS-10390 to see if it can help people with chronic kidney disease. It might slow down the disease and protect your kidneys.

Guangzhou, Guangdong
NCT07876544Recruiting· Phase 4
New drug plus amlodipine for high blood pressure and early kidney damage

This trial tests a new medicine (sitogilun malate) combined with a standard blood pressure drug (amlodipine) to see if it protects the kidneys in people with early kidney damage caused by high blood pressure. Participation could help prevent further kidney damage while controlling your blood pressure.

Shanghai, China
NCT07784621Not yet recruiting· Phase 1
Study of two drugs in healthy adults

This study tests how two investigational drugs interact when taken together in healthy adults. It looks at safety and how the drugs move through the body.

Seoul, Jongno-gu
NCT07748702Not yet recruiting· Phase 1
Study of a new drug in healthy volunteers

This trial tests a new medicine (CKD-339) in healthy people to see how the body processes it and if it is safe. It is an early-stage study that could help develop a treatment for conditions like high blood pressure or heart problems.

Seoul

Hear when a new Healthy Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.